SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-19-000265
Filing Date
2019-04-03
Accepted
2019-04-03 13:06:13
Documents
1
Period of Report
2019-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10943
  Complete submission text file 0000947871-19-000265.txt   13137
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-34951 | Film No.: 19728217

Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Issuer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 601 LEXINGTON AVE., 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVE., 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
Orbimed ROF II LLC (Reporting) CIK: 0001767936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34951 | Film No.: 19728218